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Background
Anxiety disorders and self-reported symptoms are highly
prevalent in pregnancy. Despite their negative impact on
maternal and child outcomes, uncertainty remains regarding
which symptoms can be considered accurate indicators of
antenatal anxiety.
Aims
To examine and synthesise the evidence in relation to the psy-
chometric properties and content of self-report scales used to
detect anxiety symptoms in pregnant women.
Method
A systematic search was carried out and the methodological
quality of all included studies was assessed. Only those achiev-
ing a rating of good or excellent were considered in a synthesis of
the best available evidence.
Results
Several anxiety symptoms and domains were identified as
promising for screening for general antenatal anxiety and preg-
nancy-related anxiety, including elevated levels of worry,
symptoms of panic, fear of childbirth and excessive worries
about the baby’s health.
Conclusions
This review contributes to the existing knowledge by identifying a
number of anxiety symptoms that can be considered psycho-
metrically robust indicators of antenatal anxiety.
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Anxiety during pregnancy is estimated to affect between 15 and 23%
of women and is associated with increased risk for a range of nega-
tive maternal and child outcomes.1–3 This has led to growing atten-
tion in research4,5 and clinical guidelines6 over recent years.
Antenatal anxiety has been consistently found to be a strong pre-
dictor of postnatal anxiety and depression.7–11 It has also been
linked to adverse birth and child development outcomes, including
low birth weight,12,13 premature birth3,14,15 and detrimental effects
on neurodevelopmental, cognitive and behavioural child out-
comes.4,16,17 Adverse child developmental outcomes found to be
associated with antenatal anxiety include, for example, increased
risk of language delay,16 attention-deficit hyperactivity disorder16
and poorer emotional regulation.17
Assessing anxiety in pregnancy
The importance of promoting the detection of women experiencing
antenatal anxiety has been reflected in recent clinical guidelines. In
the UK, the National Institute for Health and Care Excellence
(NICE) guidance on perinatal mental health6 has for the first time
recommended considering use of two screening questions
(Generalised Anxiety Disorder scale, GAD-2)18 for the case-identi-
fication of anxiety in pregnant and postnatal women, and the most
recent Scottish guidelines have also called for further research in this
area.19 However, the evidence for recommending the GAD-2 is pri-
marily based on its good screening accuracy in the general popula-
tion,20 with a very limited evidence base in perinatal populations.
Although clinical diagnostic interviews are the optimal method of
assessment for anxiety disorders, self-report rating scales such as
the GAD-2 are often preferred in busy clinical practice and research
because of their brevity.21
A recent systematic review found that self-reported anxiety
symptoms during pregnancy had a pooled prevalence of 22.9%
across trimesters.1 For anxiety disorders based on DSM or ICD
diagnostic criteria22,23 the overall prevalence was 15.2%. Similar
prevalence rates were reported in a number of studies showing
that problematic anxiety symptoms affect approximately 15% of
women, both in early pregnancy5 and in later stages.2,24 High
levels of self-reported symptoms, as opposed to anxiety disorders,
are of relevance as they have also been shown to be associated
with negative maternal and child outcomes.8,15 In research settings,
antenatal anxiety has been measured with a heterogeneity of self-
report scales, often in the absence of evidence of their psychometric
accuracy in pregnant populations.25
Screening for antenatal anxiety using scales developed for the
general population is problematic for various reasons, partly as a
result of the unique nature of pregnancy. One of the main concerns
relates to the emphasis of many self-report measures of general
anxiety on somatic symptoms and their potential confounding
role when questions around physical symptoms are used to screen
for anxiety during pregnancy.26,27 For instance, questions regarding
sleep disturbances or palpitations, which are relatively common
during pregnancy, may potentially lead to inflated scores. The
assessment of antenatal anxiety is further complicated by the fact
that anxiety symptoms that women can experience in pregnancy
are not limited to the range of anxiety disorders determined by
formal diagnostic criteria.22,23
Pregnancy-specific anxiety
The occurrence of pregnancy-specific anxiety has been proposed as
a distinct syndrome28 and a number of studies have investigated this
unique anxiety type.29–31 This emerging construct refers to a
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particular anxiety response related to a current pregnancy, which
can include fears and worries around labour and delivery, the
health of the baby and expected changes in a woman’s role.32
There is now good evidence of the clinical distinctiveness of
pregnancy-specific anxiety,33,34 and some studies indicate that
pregnancy-specific anxiety may be a stronger predictor of negative
child outcomes than general antenatal anxiety.34 However, women
who may be significantly anxious because of pregnancy-related
concerns might not meet the diagnostic criteria for a DSM/ICD
anxiety disorder and consequently go unrecognised.
Aims
Recent reviews on the psychometric properties of scales to measure
perinatal anxiety have highlighted this gap and the lack of anxiety
scales with sound psychometric properties for use with pregnant
women.25,35,36 However, none of these reviews have examined the
content of measures with published psychometric data in pregnant
populations. Consequently, it remains crucial to establish which
symptoms can be considered reliable and valid indicators of mater-
nal antenatal anxiety.
The aim of the present paper was to systematically examine and
synthesise both the psychometric properties and content of self-
report scales used to assess anxiety in pregnancy in order to identify
a core set of anxiety symptoms and anxiety domains with estab-
lished psychometric properties in pregnant populations. This was
achieved by conducting a systematic review of studies reporting at
least one psychometric property (i.e. one aspect of reliability or val-
idity) of a self-report measure used to assess antenatal anxiety and
by appraising and summarising the best available evidence in the
form of a narrative synthesis.
Method
The review was conducted based on guidance for undertaking
reviews of clinical tests from the Centre of Reviews and
Dissemination37 and COSMIN (COnsensus-based Standards for
the selection of health status Measurement INstruments) recom-
mendations for systematic reviews of measurement properties,38
and is reported according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement.39
Ethical approval was not required as the study only involved sec-
ondary analysis of anonymised data.
Search strategy and selection criteria
Computerised searches were performed to query the following elec-
tronic bibliographic databases: MEDLINE, PsycINFO, and the
Cumulative Index to Nursing and Allied Health Literature
(CINAHL). The initial objective of the review was to locate
primary research articles reporting psychometric properties of
self-report rating scales used to assess anxiety symptoms in a preg-
nant population.
The databases were searched from 1991 up to and including
February 2017 and searches were restricted to articles published
in peer-reviewed journals and available in English. A combination
of four main themes was used in the search. Specifically, the
major concepts searched were ‘anxiety’, ‘pregnancy’, ‘measurement’
and ‘psychometrics’ and search terms included both free text and
Medical Subject Headings (MeSH) terms. Major concepts and
related synonyms for the four main themes were searched in the
title and abstract fields, with several key terms also searched as a
major concept within each database (see supplementary Appendix
1 available at https://doi.org/10.1192/bjo.2018.75).
Reference lists and citation records of papers included in the
review were also inspected for potential inclusion of additional
studies. Reports, commentaries, conference proceedings and other
grey literature were not searched. Methodological search filters
were not applied as there is evidence that, because of the variety
of designs used in studies of diagnostic or screening test accuracy,
applying methodological filters is likely to result in the omission
of a significant number of relevant studies.40,41 A predefined list of
inclusion and exclusion criteria was applied in relation to type of
study, population, construct of interest and type of measurement.
A complete list of inclusion and exclusion criteria is provided in
the Appendix.
Study selection and data extraction
All articles resulting from the electronic bibliographic database
searches were imported into RefWorks and duplicates were
removed. Titles and abstracts of articles resulting from the initial
search were reviewed to identify potentially relevant studies.
When there was an indication that an article may have met the
inclusion criteria for the review, the full-text publication was
obtained and reviewed. The lead reviewer (A.S.) screened titles
and abstracts of all retrieved articles to determine their appropriate-
ness for inclusion in the review. A second reviewer (H.C.) independ-
ently screened a sample (10%) of all retrieved articles to establish an
index of interrater agreement determined as per cent agreement,42
which was 98% for titles and abstracts screened by both reviewers.
Discrepancies were discussed and resolved by applying the relevant
study eligibility criteria to reach consensus.
The PRISMA flow diagram39 was used to document the differ-
ent stages of the study selection process (Fig. 1). In relation to data
extraction, the full-text article of all studies included in the review
was inspected and the full version of the rating scale used was
obtained in order to extract information relevant to the review.
Data extraction forms and summary tables were developed and
piloted on a small number of studies (n = 6) identified as eligible
for inclusion at an early stage of the review.
For each included study the following information was
extracted: (a) author/s, (b) year of publication, (c) country,
(d) name of index test, (e) sample size, (f) timing of assessment
(expressed as trimester or mean gestational week), (g) construct
of interest. For each of the rating scales, we extracted: (a) number
of items, (b) type and number of response options (for example
Likert scale, dichotomous), (c) time frame assessed (for example
past week, past month), (d) score range, (e) total possible score,
(f) cut-off score (if available). In order to determine which psycho-
metric properties were evaluated in each study, the COSMIN tax-
onomy and definitions of measurement properties were used.43
The following psychometric properties were extracted: internal con-
sistency reliability, construct validity, convergent and discriminant
validity, structural (i.e. factorial) validity and criterion validity.
Definitions of all psychometric properties examined in this review
and their corresponding indexes are presented in supplementary
Appendix 2.
Quality assessment
An assessment of the methodological quality of each study included
in the review was conducted using the COSMIN checklist, specific-
ally developed to evaluate the study quality and risk of bias in sys-
tematic reviews of studies on the measurement properties of
health measurement instruments.44 In this review, five of the nine
possible boxes in the checklist were employed as they were consid-
ered to be relevant to evaluate the methodological quality of studies
assessing the construct of anxiety in pregnancy.
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Specifically, these were box A (internal reliability), D (content
validity), E (structural validity), F (hypotheses testing) and H (criter-
ion validity). Each measurement property is scored on a four-point
rating scale as ‘poor’, ‘fair’, ‘good’ or ‘excellent’. An overall score for
the methodological quality of a study is determined by using a
‘worse score counts’ system.45 The lead reviewer (A.S.) performed
the quality assessment for all studies included in the review, with
the second reviewer (H.C.) assessing a random sample of studies
(n = 5) to confirm the accuracy of the scoring system. It was
decided that only studies that achieved an overall rating of good or
excellent were considered in the best-evidence synthesis in order to
guarantee the quality of the conclusions reached by the review.
Best-evidence synthesis
The main aim of this review was to examine the psychometric prop-
erties and content of anxiety measures used in pregnancy, both at
the scale and at the item level, in order to identify specific items
(i.e. questions) or anxiety domains with established psychometric
properties in this population. A synthesis of the best available
evidence is presented for each scale in a narrative form, as the con-
siderable differences across studies in relation to measure used,
sample size, time of administration and type of reliability or validity
reported precluded a meta-analysis. At the scale level, the psycho-
metric properties discussed above were examined and synthesised.
The number of studies, their methodological quality and the con-
sistency of findings were taken into account.
Specifically, the following criteria were used to classify the strength
of evidence from one or more studies, based on COSMIN recommen-
dations for quality criteria:46 (a) strong evidence: consistent findings in
multiple studies of good or excellent methodological quality or in one
study of excellent quality, (b) moderate evidence: consistent findings
in multiple studies of good or excellent quality, except for one study
with contrasting findings, (c) limited evidence: one study of good
methodological quality, and (d) unclear or conflicting evidence:
contrasting results in multiple studies of good quality. Only items
and anxiety domains with moderate or strong evidence of being
accurate indicators of anxiety symptoms in pregnancy were consid-
ered psychometrically sound in assessing antenatal anxiety.
At the item level, the analysis was primarily based on factor ana-
lysis, and specifically on the examination and comparison of coeffi-
cients of item loadings on specific anxiety factors for each scale. In
psychometrics, the examination of item loadings is recommended
in order to determine which items within a scale possess the stron-
gest psychometric properties in terms of their discriminative
power,47 and can be therefore considered to detect an important
aspect of the construct assessed.48 Factor analysis is used to
reduce variables (i.e. single items) that share common variance
into set of clusters (i.e. factors).49
In this review, the criteria proposed by Tabachnick & Fidell50 and
listed as follows were adopted to evaluate the strength of item loading
coefficients: (a) 0–0.44, poor; (b) 0.45–0.54, fair; (c) 0.55–0.62, good;
(d) 0.63–0.70, very good; (e) >0.70, excellent. Only items that
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Fig. 1 PRISMA flow diagram of the selection process (based on Moher et al).39
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showed very good or excellent loadings (i.e. 0.63 or above), and for
which the strength of evidence from one or multiple studies was mod-
erate or strong according to the criteria discussed above, were consid-
ered to be psychometrically sound in measuring anxiety symptoms in
pregnancy.When items forming a factor were found to be particularly
homogeneous in relation to their content, the entire dimension or
domain that the factor represented rather than individual items
was selected as a domain identified as psychometrically sound.
Secondary indexes that were examined at the item level when
factor analysis was not conducted were the correlations between
individual items and the remainder of items within a scale (corrected
item-total correlations) and item discrimination parameters for
analyses based on item-response theory models.
Results
The initial search yielded 2879 citations, which were reduced to
1756 following de-duplication. The titles and abstracts of remaining
articles were screened for potentially eligible studies, resulting in 74
publications for which the full-text article was retrieved. At this
stage 47 studies were excluded and 2 publications were added
from hand searches of reference lists of included studies. This
resulted in a final sample of 29 studies included in the
review.8,11,28,31,33,51–74 The main reasons for excluding studies
after retrieving the full text were: (a) no psychometric data available,
(b) construct of interest different from inclusion criteria (for
example antenatal stress, general mental health), (c) study partici-
pants recruited exclusively from high-risk samples. The study selec-
tion process is summarised in the PRISMA flowchart (Fig. 1).
The 29 included studies used 9 different scales as index tests to
measure antenatal anxiety. The most commonly reported psycho-
metric properties were internal consistency reliability (n = 27; 93%
of studies), convergent validity (n = 21; 72%) and structural validity
(n = 16; 55%). The characteristics of included studies are presented
in Table 1. Included studies showed a considerable degree of hetero-
geneity in relation to the construct assessed (i.e. general anxiety
versus an anxiety disorder versus pregnancy-specific anxiety), gesta-
tional age of participants, sample size and type of psychometric
properties reported.
As discussed in the Method, a quality assessment of all included
studies was performed and only studies achieving a rating of good or
excellent in relation to their methodological quality and risk of bias
were included in the best-evidence synthesis. Seven studies were
given a rating of poor59,68,72 or fair56,62,65,70 for their methodological
quality and were thus not considered in the synthesis. The quality
assessment of all 29 studies included in the review is presented in
the supplementary Table 1. Further details about the criteria used
to rate the methodological quality of all studies included are avail-
able from the corresponding author on request.
Best-evidence synthesis
Following an assessment of the methodological quality of all studies,
22 were included in the best-evidence synthesis phase of the
review.8,11,28,31,33,51–55,57,58,60,61,63,64,66,67,69,71,73,74 This section dis-
cusses the findings from these studies through an examination of
the psychometric properties of each scale and a critical analysis of
the content of their items and anxiety domains found to be psycho-
metrically sound for the assessment of antenatal anxiety. This ana-
lysis was carried out accordingly to the criteria discussed in detail in
the Method. For clarity of exposition, a synthesis is presented here
separately for each scale, whereas the Discussion summarises the
general findings of the review.
Edinburgh Postnatal Depression Scale (EPDS) – Anxiety
subscale
The EPDS75 is a ten-item self-report questionnaire originally devel-
oped to screen for postpartum depression, which asks respondents
about symptoms of depression experienced in the previous week.
Because of the lack of items specific to the postpartum period, the
EPDS has also been validated for use with pregnant women.76,77
Although the EPDS was developed as a unidimensional measure
of depression, it was included in this review because of growing evi-
dence that it contains a separate subscale measuring anxiety rather
than depressive symptoms, in both antenatal and postnatal
populations.78–80
Six studies included in this review examined the psychometric
properties of the EPDS anxiety subscale in pregnant women. All
studies except one70 achieved an overall methodological quality
rating of good52,67,71 or excellent54,63 and were thus included in
the best-evidence synthesis. Four of the five studies examined the
factor structure of the EPDS to investigate whether the existence
of an anxiety subscale could be confirmed.
Brouwers and colleagues52 performed exploratory factor ana-
lysis (EFA) of EPDS scores in women in their second trimester of
pregnancy. The EFA revealed three components within the EPDS,
namely two separate depressive (items 1, 2, 8) and anxiety (items
3, 4, 5) symptoms subscales and a third component consisting
only of item 10 (‘The thought of harming myself has occurred to
me’). However, this third factor was not included in the final
factor solution as the authors argued that a single-item loading
could not plausibly identify a distinct latent factor.52 A two-factor
solution, comprising separate depression and anxiety subscales,
was therefore proposed. The three items of the anxiety subscale
(item 3 ‘I have blamed myself unnecessarily when things went
wrong’, item 4 ‘I have been anxious or worried for no good reason’,
item 5 ‘I have felt scared or panicky for no very good reason’) were
the only ones, among the ten EPDS items, with item loadings on a
single factor above the predefined cut-off of 0.63, ranging from 0.68
(item 3) to 0.73 (item 4). An examination of their content appears
to indicate that these questions, all loading highly on a single factor,
tap important affective and cognitive components of anxiety (for
example feeling panicky or worried).
Similar findings were reported by Jomeen & Martin63 in
women in their first trimester of pregnancy. EFA resulted in a
three-factor solution that included depression and anxiety dimen-
sions, and the same third factor identified by Brouwers and collea-
gues.52 The items loading significantly (>0.63, range 0.73–0.85)
onto the anxiety subscale were entirely consistent (items 3, 4, 5)
with those identified in the previous study.52 The authors then
conducted confirmatory factory analysis (CFA), a more refined
data reduction technique than EFA,81 and tested various prede-
fined factor models including the original unidimensional
depression model,75 as well as both a two- and a three-factor
model identified by Brouwers and colleagues.52 Results from the
CFA revealed once again a clear superiority of the two-factor solu-
tion, thus confirming the previous finding that the EPDS both in
early and in mid-pregnancy consistently measures two distinct
dimensions of depression and anxiety.
A further study included in this review67 used the three-item
EPDS anxiety subscale (EDS-3A) identified in previous studies to
examine its criterion and convergent validity in pregnancy when
compared with other anxiety measures. The EDS-3A performed
better than both the anxiety subscale of the Hospital Anxiety and
Depression Scale (HADS-A82) and the Pregnancy Related Anxiety
Questionnaire-Revised (PRAQ-R28) in detecting women with an
anxiety disorder as determined by DSM diagnostic criteria.
Furthermore, the EDS-3A showed a moderately high correlation
Sinesi et al
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Table 1 General characteristics of studies included in the review
Authors Year Participants, n Gestational age Country Index test Time frame assessed Target construct
Austin et al11 2007 748 3rd trimester Australia BMWS ‘General experience’ Worry
Bayrampour et al51 2014 3021 2nd trimester Canada STAI (3 six-item short forms) State (present time); trait (general feelings) State/trait anxiety
Brouwers et al52 2001 197 24 weeks Netherlands EPDS-A Previous week General anxiety
Carmona Monge et al53 2012 285 Mean 14.1 weeks Spain CWS Present time Worry during pregnancy
Coates et al54 2016 5551 18 and 32 weeks UK EPDS-A Previous week General anxiety
Fenaroli & Saita55 2013 522 27–35 weeks Italy W-DEQ Current expectations about childbirth Fear of childbirth
Garthus-Niegel et al56 2011 1642 32 weeks Norway W-DEQ Current expectations about childbirth Fear of childbirth
Gourounti et al57 2012 132 11–14 weeks Greece CWS Present time Worry during pregnancy
Grant et al8 2008 100 35–39 weeks Australia STAI (state and trait forms) State (present time); trait (general feelings) State/trait anxiety
Green et al58 2003 1207 1st/2nd/3rd trimester UK CWS Present time Worry during pregnancy
Haines et al59 2015 1410 2nd trimester Australia W-DEQ Current expectations about childbirth Fear of childbirth
Huizink et al28 2004 172 1st/2nd/3rd trimester Netherlands PRAQ-R Present time Pregnancy-related anxiety
Huizink et al31 2016 1144 24 and 34 weeks Finland PRAQ-R2 Present time Pregnancy-related anxiety
Johnson & Slade60 2002 424 3rd trimester UK W-DEQ Current expectations about childbirth Fear of childbirth
Jomeen & Martin61 2004 101 Mean 13.57 weeks UK HADS-A Previous week General anxiety
Jomeen & Martin62 2005 129 Mean 13.86 weeks UK CWS Present time Worry during pregnancy
Jomeen & Martin63 2005 101 Mean 13.57 weeks UK EPDS-A Previous week General anxiety
Karimova & Martin64 2003 100 12 and 34 weeks UK and Uzbekistan HADS-A Previous week General anxiety
Levin65 1991 266 2nd trimester USA PAS Present time Pregnancy-related anxiety
Marteau & Bekker66 1992 200 Gestational age not reported UK STAI (six-item short form) Present time State anxiety
Matthey et al67 2013 132 Mean 14.9 weeks Australia EPDS-A, HADS-A, PRAQ-R Various time frames General and pregnancy-related anxiety
Öhman et al68 2003 200 8–42 weeks Sweden CWS Present time Worry during pregnancy
Petersen et al69 2009 344 Mean 31.4 weeks Germany CWS Present time Worry during pregnancy
Simpson et al70 2014 240 1st trimester Canada EPDS-A, GAD-7 Previous week General anxiety
Swalm et al71 2010 4706 10–42 weeks Australia EPDS-A Previous week General anxiety
Tendais et al72 2014 148 1st/2nd/3rd trimester Portugal STAI-S Present time State anxiety
Westerneng et al33 2015 6004 Mean 19.8 weeks Netherlands PRAQ-R Present time Pregnancy-related anxiety
Wijma et al73 1998 196 32 weeks Sweden W-DEQ Current expectations about childbirth Fear of childbirth
Zhong et al74 2015 946 Mean 9.6 weeks Peru GAD-7 Previous two weeks Generalised anxiety disorder
BMWS, Brief Measure of Worry Severity; STAI, State-Trait Anxiety Inventory; EPDS-A, Edinburgh Postnatal Depression Scale – Anxiety subscale; CWS, Cambridge Worry Scale; W-DEQ, Wijma Delivery Expectancy/Experience Questionnaire; PRAQ-R and PRAQ-R2, Pregnancy-
Related Anxiety Questionnaire- Revised; HADS-A; Hospital Anxiety and Depression Scale – Anxiety subscale; PAS, Pregnancy Anxiety Scale; GAD-7, Generalised Anxiety Disorder – 7.
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with the HADS-A (r = 0.68) and a low to moderate correlation with
the PRAQ-R (r = 0.23), which may be interpreted as an indication
that the three measures tap into different aspects of antenatal
anxiety.
Although a potential limitation of the three studies reported
above is their relatively small number of participants (n < 200),
the existence of an anxiety subscale within the EPDS was further
confirmed in two subsequent studies with much larger numbers
of participants (n > 4000). Swalm and colleagues71 examined the
EPDS factor structure in Australian women across the three trime-
sters of pregnancy. A two-factor solution consisting of anxiety and
depression components was found once more to be optimal,
accounting for 55% of the score variance (anxiety subscale 29.4%;
depression subscale 25.4% of the total variance). Moreover, an ana-
lysis of individual item loadings confirmed that items 3, 4 and 5
were the only ones with loadings higher than 0.63 on the anxiety
subscale (range 0.75–0.78).
A recent UK population-based study54 conducted both EFA and
CFA on a large number of participants at two time points (18 and 32
weeks’ gestation). Although both EFA and CFA indicated a three-
factor model as the best factor solution, this was primarily
because of the ‘depression’ factor that was split into an anhedonia
(items 1 and 2) and a depression (items 7–10) factor. Importantly,
this was the only study in which item 3 ‘I have blamed myself
unnecessarily when things went wrong’ (0.56) did not reach the pre-
defined item loading coefficient of 0.63.
In summary, according to the criteria previously discussed to
evaluate the strength of evidence in relation to the psychometric
properties of reviewed scales, item 3 of the EPDS showed moderate
evidence of its psychometric value, and items 4 and 5 demonstrated
strong evidence of being psychometrically sound in assessing ante-
natal anxiety, as their item loadings on the anxiety subscale consist-
ently exceeded the 0.63 cut-off in all reviewed studies.
HADS – Anxiety subscale
The HADS82 is a widely popular screening tool83 originally devel-
oped to assess anxiety and depression in non-psychiatric patients.
This 14-item measure consists of two subscales (anxiety: HADS-
A; depression: HADS-D), both comprising seven items and enquir-
ing about feelings over the past week with four response options.82 It
is particularly important to establish the psychometric properties of
the HADS when used in the antenatal period, as a considerable
number of studies have used this screening tool to assess anxiety
and depression levels in pregnant women, including in recent
years.5,84
Three studies included in this review examined psychometric
aspects of the HADS in a pregnant population.61,64,67 They all
achieved a rating of good in relation to their methodological
quality. Karimova & Martin64 investigated the factor structure of
the HADS in the third trimester of pregnancy by conducting EFA
of HADS scores in nulliparous women, and a post hoc factor analysis
revealed a two-factor solution. Specifically, six of the sevenHADS-D
items loaded higher on one factor and an equal number of HADS-A
items loaded higher on a second factor. However, there was signifi-
cant overlapping of item loadings on the two subscales, with only
four HADS-A items (item 3 ‘I get a sort of frightened feeling as if
something awful is going to happen’; item 5 ‘Worrying thoughts
go through my mind’; item 9 ‘I get a sort of frightened feeling like
“butterflies” in the stomach’ and item 13 ‘I get sudden feelings of
panic’) loading above 0.63 on the anxiety factor. The authors there-
fore concluded that the seven-item HADS-A and HADS-D sub-
scales do not reliably distinguish between anxiety and depressive
symptoms in pregnancy.
A further study was conducted by Jomeen & Martin61 on
women in early pregnancy. Both EFA and CFA revealed a three-
factor solution that confirmed that the HADS in pregnancy is not
a bi-dimensional measure of anxiety and depression. However, a
comparison of individual item loadings of the HADS anxiety sub-
scale in the two studies was carried out in this review to examine
psychometric information for each individual item within the
HADS anxiety subscale. This is presented in Table 2.
The observation that three items of the HADS-A (items 3, 5, 13)
are the only ones to reach an item loading above 0.63 on the anxiety
factor in both studies is of particular importance. Although the two
studies reached the conclusion that the seven-item HADS-A as a
whole is not a psychometrically sound measure of anxiety in preg-
nancy, the three HADS-A items identified here showed a consistent
pattern across the two studies, with significantly similar loadings on
the anxiety factor. These items would therefore appear to have good
psychometric value in assessing specific anxiety symptoms in
pregnancy.
A subsequent study67 compared the screening performance of
the HADS-A with diagnosis of an anxiety disorder according to
DSM criteria. The authors found that high anxiety scores on the
HADS-A, defined as the top 15% of scores, had poor concordance
(34%) with formal diagnosis of an anxiety disorder. The poor con-
cordance with DSM diagnoses seems to confirm the previous find-
ings indicating that the seven-item HADS anxiety subscale as a
whole is not a reliable screening tool to assess anxiety in pregnancy.
However, based on the evidence provided by the two studies dis-
cussed above on the factor structure of the HADS, we conclude
that the three identified items represent a shortened version of the
HADS-A which, unlike the entire HADS-A, has good evidence of
its psychometric properties to measure antenatal anxiety.
State-Trait Anxiety Inventory (STAI)
The STAI85 comprises two subscales, each composed of 20 items. It
is based on a model of anxiety that distinguishes between state and
trait anxiety.86 State anxiety refers to the situation-specific, transient
component of anxiety. Conversely, trait anxiety reflects a relatively
stable personality trait, a dispositional anxiety proneness.58
Response options range from one (not at all) to four (very much
so) for both the state and trait form, and each scale includes ten
anxiety-present (for example ‘I am worried’) and ten anxiety-
absent (for example ‘I feel secure’) items. The state form asks parti-
cipants about feelings at the present time, whereas the trait form
Table 2 Item loading coefficients of the Hospital Anxiety and
Depression Scale – Anxiety subscale (HADS-A) subscale in Karimova &
Martin64 and Jomeen & Martin61
HADS-A items
Karimova &
Martin (2003)
Anxiety factor
(factor 2)
Jomeen &
Martin (2004)
Anxiety factor
(factor 2)
1. I feel tense or wound up 0.18 0.31
3. I get a sort of frightened feeling as if
something awful is going to
happen
0.67a 0.74a
5. Worrying thoughts go through my
mind
0.78a 0.69a
7. I can sit at ease and feel relaxed 0.33 0.07
9. I get a sort of frightened feeling like
‘butterflies’ in the stomach
0.65a 0.57
11. I feel restless as if I have to be on
the move
0.57 0.36
13. I get sudden feelings of panic 0.67a 0.75a
a.Item loadings of 0.63 or above.
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enquires about how a respondent generally feels. The STAI has been
widely validated in the general population11 and is one of the most
common measures used in research to assess anxiety in perinatal
women.35
This review located four studies reporting psychometric proper-
ties of the STAI in pregnant populations, one of which72 was scored
poor in relation to its methodological quality. Both the state and
trait form of the STAI were used in an Australian study by Grant
and colleagues8 on women in the third trimester of pregnancy.
Internal consistency was found to be high for the full version of the
scale, with a Cronbach’s alpha (α) of 0.95. A structured diagnostic
interview was also used (Mini International Neuropsychiatric
Interview)87 to identify women meeting DSM-IV diagnostic criteria
for an anxiety disorder. The authors found a cut-off score of 40 to
yield the highest accuracy in identifying women with a diagnosed
anxiety disorder, with a sensitivity of 80.9% and a specificity of
79.7%.8 However, they also acknowledged the limited generalisability
of the findings because of the relatively small number of participants.
The study did not provide any psychometric data at the item level and
it was thus not possible to reach conclusions on the psychometric
qualities of individual items measuring specific symptoms.
A further study66 tested various shortened versions of the STAI-
S form to determine the smallest subset of items that preserved high
correlations (r > 0.90) with the original, 20-item STAI-S. They
found that a six-item version produced scores comparable with
the full version (r > 0.94) while retaining a good level of internal
consistency (α = 0.82). The six items selected were the ones with
the highest correlations with the remaining 19 items of the STAI-
S (i.e. corrected item-total correlations). Specifically, the authors
identified three anxiety-present and three anxiety-absent items, cor-
responding to the following emotional states: calm, tense, upset,
relaxed, content and worried. This is a significant finding, as it iden-
tifies a number of symptoms (i.e. feeling tense, upset or worried)
that correlate highly with the 20-item STAI-S total score, providing
an initial indication that these anxiety-present symptoms may be
considered relatively accurate indicators of problematic anxiety in
pregnancy.
This was confirmed in a further study by Bayrampour and col-
leagues51 that examined the psychometric properties of three six-
item shortened versions of the STAI-S when compared with the
full state form. The three short versions are the ones discussed
above66 and two other versions developed in non-perinatal popula-
tions. The six-item version by Marteau & Bekker66 had the highest
correlation with the sum score of the full form (r = 0.94).
Furthermore, confirmatory factory analysis was conducted and
the version by Marteau & Bekker66 was found once more to consist-
ently have the best values for all fit indexes considered, with the
three anxiety-present items (i.e. feeling tense/upset/worried) all
found to have coefficient item loadings above 0.63, a further indica-
tion of their psychometric soundness.
In sum, the three items from the STAI-S short form discussed
above were identified in two studies of good methodological
quality51,66 as potentially reliable indicators of anxiety symptoms
during pregnancy.
GAD-7
The GAD-718 was developed in 2006 as a brief screening measure
for generalised anxiety disorder. Its original psychometric validation
study, in a large number of primary care patients indicated very
good screening accuracy in identifying people with a diagnosis of
generalised anxiety disorder.18 The scale consists of seven items
asking respondents about some of the core generalised anxiety dis-
order symptoms (for example excessive or persistent worry, trouble
relaxing) experienced in the previous 2 weeks. As previously
discussed, the first two questions of the GAD-7 (GAD-2) have
been recently recommended by NICE as a brief screening
measure for anxiety in perinatal women.6
Only two studies examining the measurement properties of the
GAD-7 in a pregnant population were identified by this review,70,74
and only one74 achieved a satisfactory rating for its methodological
quality. Importantly, this was one of the few included studies that
performed assessment of a scale against a gold-standard clinical
interview, the Composite International Diagnostic Interview,88 to
determine the criterion validity of the scale. In this antenatal
sample at a cut-off score of seven or above, notably different from
the cut-off of ten identified in the general population, the measure
yielded moderately good sensitivity (73%) and specificity (67%).74
Internal consistency was close to excellent (α = 0.89).
Both EFA and CFA were conducted, and confirmed the unidi-
mensional structure (i.e. a single factor) of the GAD-7 previously
found in the general population.18 The results of the factor analysis
indicated that the seven items loaded on a single factor with item
loadings all exceeding 0.63. In order to identify which items pro-
vided the most accurate screening performance we thus examined
the item discrimination parameters, which are based on item-
response theory and indicate how well individual items differentiate
between different levels of the target condition among respon-
dents.89 Two items showed considerably higher discrimination
parameter estimates than the remaining ones. These were item
3 ‘Worrying too much about different things’ (2.05) and item 2
‘Not being able to stop or control worrying’ (2.04), which clearly
tap into the experience of pervasive or persistent worry typical of
generalised anxiety disorder. All other items exhibited substantially
lower discrimination parameter estimates. Considering that this
study was of excellent methodological quality, the two identified
items have consequently strong evidence of their psychometric
value in the antenatal period.
Brief Measure of Worry Severity (BMWS)
A single study11 was located reporting psychometric data of the
BMWS90 in pregnant women. Self-report scales assessing the con-
struct of ‘worry’ were included in this review (Appendix 1) as
worry is a core clinical feature of generalised anxiety disorder.22,91
A number of studies indicate that generalised anxiety disorder is
the most common anxiety disorder in pregnancy1,72 and for this
reason worry can be hypothesised to be an important dimension
of the construct of antenatal anxiety. The BMWS was developed
as a unidimensional measure of the functional impact and severity
of worry.90 It includes eight items assessing different aspects of
worry. Respondents are asked to rate their general or usual experi-
ence of worrying, with four verbally anchored response options (not
true at all – definitely true).90
Austin et al aimed to determine whether the construct of worry
as measured by the BMWS, defined as ‘dysfunctional trait cognitive
anxiety’, was a significant predictor of postnatal depression.11
Internal consistency was very good (α = 0.89) and the BMWS also
showed good convergent validity with the STAI trait (r = 0.71).
Although psychometric properties of the scale at the item level
were not reported, there was evidence that the construct of worry
as measured by the BMWS is a reliable indicator of antenatal
anxiety. First, the BMWS was found to have good construct validity
in these pregnant participants, as it showed significant correlations
with a number of other variables linked to a current episode of
anxiety and depression.11 Moreover, it was a better predictor of
postnatal depression than the STAI-S after controlling for possible
confounding factors. As the literature indicates that antenatal
anxiety is a predictor of postnatal depression,7,8,10 it appears than
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the BMWS taps into a core component of antenatal anxiety consid-
ering its good predictive validity.
Consequently, the construct of worry has strong evidence of
being psychometrically robust according to the criteria used in
this review (i.e. consistent findings in multiple studies of good or
excellent methodological quality) as it was also identified as psycho-
metrically sound in other studies previously discussed in this
synthesis.
Cambridge Worry Scale (CWS)
The CWS is a 16-item measure assessing the extent and content of
women’s worries during pregnancy.58 The 16 items in the CWS
enquire both about worries specific to pregnancy, such as ‘The pos-
sibility of miscarriage’, ‘The possibility of something being wrong
with the baby’ or ‘Giving birth’, and more general concerns includ-
ing ‘Money problems’ and ‘Your relationship with your family and
friends’. Items are scored on a six-point Likert-type scale with ver-
bally described anchors ranging from zero (not a worry) to five
(major worry) and referring to the present time.58
Six studies examining psychometric aspects of the CWS in a
pregnant population were included in this review, four of which
are considered here. The other two studies were rated as poor68 or
fair62 for their methodological quality.
Green and colleagues58 were the first to investigate the struc-
tural validity (i.e. the factor structure) of the CWS. A longitudinal
design was used in a large number (n = 1207) of British women
completing the CWS at gestational weeks 16, 22 and 35. The
authors analysed scores at these three time points by means of
principal component analysis (PCA), a form of exploratory factor
analysis. The PCA revealed a four-factor structure, consisting of
the following factors: (a) socio-medical aspects of having a baby,
(b) socio-economic issues, (c) health of mother and baby, and
(d) relationships with partner, family and friends. This four-factor
solution was subsequently replicated in all the other studies exam-
ined in this synthesis.53,57,69 This can be considered robust evidence
of factorial stability of the CWS in different populations and stages
of pregnancy.
The convergent validity of the CWS was examined by compar-
ing it with STAI state and trait scores57,58,69 and with the anxiety
subscale of the Symptom Checklist-9092 by Carmona Monge and
colleagues.53 Two of the four CWS subscales were found to have
the highest correlations with state anxiety (STAI-S) scores across
studies. These were the ‘socio-medical’ and the ‘health of mother
and baby’ factors. For the purpose of this review, we specifically
focused on these two factors, both because of their higher correla-
tions with state anxiety and because the content of items in these
subscales appears to reflect worries more closely related to preg-
nancy. Thus, an examination of individual item loadings for these
two factors was carried out.
In relation to the ‘socio-medical’ subscale, one item (‘Giving
birth’) was found to load above the predefined criterion of 0.63 in
all studies, thus demonstrating strong evidence of its psychometric
properties in assessing a major worry in pregnancy. Another three
items showed moderate strength of evidence as they loaded above
0.63 on the ‘socio-medical’ subscale in all studies apart from one.
Specifically, ‘Internal examinations’ had an item loading coefficient
of 0.61 in Gourounti and colleagues,57 but item loadings above 0.63
in all the other studies; ‘Going to hospital’ (0.68–0.79), apart from
Gourounti and colleagues57 (0.47); and ‘Coping with the new
baby’ (0.65–0.68), except for the study by Petersen and colleagues,69
in which its loading was 0.58.
An inspection of the second factor examined, ‘Health of mother
and baby’, indicated two further items with loadings >0.63 in all the
studies, namely ‘The possibility of miscarriage’, which ranged
between 0.7558 and 0.8553, and ‘The possibility of something being
wrong with the baby’ (range 0.65–0.8353,58). The other two items
included in this subscale, ‘Own health’ and ‘Health of someone else
close’, consistently loaded below the pre-defined cut-off.
In summary, three items of the CWS (‘Giving birth’, ‘The pos-
sibility of miscarriage’, ‘The possibility of something being wrong
with the baby’) demonstrated strong evidence of their psychometric
properties. Three further items (‘Internal examinations’, ‘Going to
hospital’ ‘Coping with the new baby’) showed a moderate strength
of evidence of their psychometric value in pregnancy.
Wijma Delivery Expectancy/Experience Questionnaire
(W-DEQ – Version A)
The W-DEQ73 was developed in the late nineties to assess the
construct of fear of childbirth. Within the research literature on preg-
nancy-specific anxiety, fear of childbirth or tokophobia has emerged
as a central dimension of pregnancy-specific anxiety.5,34,93 The
W-DEQ Version A73 includes 33 items enquiring about thoughts
and feelings relating to the approaching childbirth, with six response
options ranging from ‘not at all’ to ‘extremely’.
Five studies included in the present review reported psychomet-
ric information on the W-DEQ in an antenatal popula-
tion,55,56,59,60,73 and three studies achieved a good or excellent
methodological quality rating.55,60,73 In the original development
study of the W-DEQ,73 internal consistency of the measure was
excellent (α = 0.93). The authors also provided good evidence of
the face and construct validity of the W-DEQ, with all items formu-
lated based on the clinical experience of the first two authors
and incorporating women’s input in the wording of items. The
W-DEQ showed higher correlations with other anxiety measures
than with extraversion or depression measures. However, these cor-
relations were only moderate (STAI-T: r = 0.54; S-R Inventory of
anxiousness: r = 0.52), thus showing a degree of conceptual
overlap but also a sufficient level of variance left to indicate that
the W-DEQ measures other than anxiety as a dispositional trait.73
At the item level, item-total correlations were ranked and the
authors examined the ten items with the highest ranking. Two
domains of fear of childbirth, ‘Negative feelings towards childbirth’
and ‘Fear of labour and delivery’, were identified among the items
more strongly correlated with the sum score, thus suggesting a stron-
ger relation with the overall construct of fear of childbirth. As single
items composing the W-DEQ are very specific to a given feeling or
cognitive appraisal, we considered it appropriate to focus on
domains of fear of childbirth rather than individual items.
Two other studies55,60 included in this synthesis conducted
factor analysis of W-DEQ scores and found four distinct dimen-
sions of the construct of fear of childbirth as measured by the
scale. Johnson & Slade60 named the four identified domains Fear,
Lack of positive anticipation, Isolation and Riskiness. The latter
two refer to feelings of isolation related to childbirth and to the
extent to which women anticipate risks for the child during delivery.
Fenaroli & Saita55 also found a four-factor structure of the W-DEQ,
and although the four domains were named with slightly different
labels than those used by Johnson & Slade60, the four factors were
considerably similar and had a high degree of conceptual overlap.
In this best-evidence synthesis two dimensions of pregnancy-spe-
cific anxiety, namely Fear of labour and delivery and Negative feel-
ings towards childbirth (corresponding to Lack of positive
anticipation in Fenaroli & Saita55), were thus found to exhibit
strong evidence of being psychometrically sound in assessing this
specific aspect of antenatal anxiety. A third dimension (Fear for
baby’s health) showed moderate strength of evidence as, although
it was identified in two studies,55,60 contrasting results were found
in another study.73
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PRAQ-R and PRAQ-R2
This pregnancy-specific anxiety measure is composed of ten items
assessing various manifestations of anxiety related to a current preg-
nancy. Each item asks about feelings at the present time and has five
response options ranging from ‘never’ to ‘very often’. Its original
version (PRAQ)94 consisted of 58 items and was developed based
on previous anxiety measures.
The first study testing the psychometric properties of the
PRAQ was carried out by Huizink and colleagues28 who initially
tested a revised, 34-item version (PRAQ-R28) of the original
PRAQ on 230 nulliparous women. The authors’ aim was to
examine the factorial structure of the PRAQ-R and test the
hypothesis that pregnancy-specific anxiety could be differentiated
from general anxiety by comparing STAI and PRAQ-R scores.
They found that only between 8 and 27% of the PRAQ-R variance
was accounted for by the index of general anxiety at different time
points during pregnancy, with no linear association found
between the two measures. This was interpreted as evidence of
the distinctiveness of the pregnancy-specific anxiety construct28
and highlighted once more that measures of general anxiety
cannot be accurately used to identify women experiencing fears
and worries specific to pregnancy.
The authors initially conducted EFA and removed a number of
items because of high error variance, resulting in a final version
comprising ten items (PRAQ-R). A subsequent CFA revealed
that a solution with three factors provided the best fit to the
data, with the three identified factors labelled by the researchers
‘Fear of giving birth’ (three items), ‘Fear of bearing a physically
or mentally handicapped child’ (four items) and ‘Concern about
one’s appearance’ (three items). All individual items loaded on
one of the factors above the cut-off of 0.63, except for one item
(0.50), ‘I am worried about not being able to control myself
during labour and fear that I will scream’. Similarly to the
approach used for the W-DEQ and discussed above, we consid-
ered the whole factors rather than individual items making up a
given factor.
Two further studies31,33 included here tested the measurement
properties of the PRAQ-R, and both replicated the previous
finding of a three-factor structure of the PRAQ-R by means of
CFA. As the original participants of the ten-item PRAQ-R were
exclusively composed of nulliparous women, Westerneng and col-
leagues33 aimed to test the factorial stability of the three-factor
solution of the PRAQ-R28 on a large (n > 6000) data-set of both
nulliparous and parous women. This involved the deletion of
item 8 ‘I am anxious about the delivery because I have never
experienced one before’, as it was not suitable for use with
women who had already experienced childbirth. CFA confirmed
the same three-factor structure of the original ten-item PRAQ-R
with good indexes of fit to the data for both nulliparous and
parous women.
Three factors were also found in a recent study31 that replaced
item eight of the original PRAQ-R with the more generic ‘I am
anxious about the delivery’ in order to preserve a ten-item scale
while making it appropriate for all pregnant women irrespective
of parity (PRAQ-R2)31. All item loadings were once more above
0.63 (range: 0.70–0.93) except for two items, ‘I am worried about
not being able to control myself during labour and fear that I will
scream’, similarly to Huizink and colleagues,28 and ‘I sometimes
think that our child will be in poor health or will be prone to
illnesses’.
In summary, across the three studies examined here28,31,33 eight
items from the PRAQ-Rwere found to consistently have high loadings
on one of three factors (i.e. pregnancy-specific anxiety domains).
These three pregnancy-specific anxiety domains, namely ‘Fear of
giving birth’, ‘Fear of bearing a physically or mentally handicapped
child’ and ‘Concern about one’s appearance’, were all identified in
studies of good or excellent methodological quality, thus providing
strong evidence of being accurate indicators of pregnancy-specific
anxiety.
Discussion
There are several important findings to this study. First, this review
has identified a number of anxiety items and domains from existing
self-report scales with demonstrated psychometric value when used
to assess symptoms of anxiety in pregnant women. To the best of
our knowledge, this is the first study to analyse the content of
self-report anxiety measures used in the antenatal period and
provide recommendations for the accurate assessment of maternal
antenatal anxiety based on a systematic synthesis of published psy-
chometric data.
A second, significant finding of this paper is that it highlights the
scarcity of studies reporting psychometric properties of scales
employed to measure anxiety in pregnancy. A considerable
number of studies using self-report scales to assess antenatal
anxiety were not included in this review as no measurement prop-
erties of the scale used were reported. It would appear that in most
cases researchers have selected a given anxiety measure only based
on its widespread use and good psychometric properties in the
general population.36 However, assuming that the measurement
properties of a psychological scale developed for the general popu-
lation are preserved in pregnancy is incorrect for various reasons
discussed earlier in this paper (i.e. undue emphasis on somatic
symptoms, lack of validated cut-off scores and norms for pregnant
populations, role of pregnancy-specific anxiety).
A further limitation of the literature is that only a dearth of
studies located by this review (n = 5)8,67,70,72,74 validated a
measure against a reference ‘gold’ standard such as a structured
diagnostic interview. Testing a scale against a reference standard
provides evidence of the screening accuracy of a measure, also
referred to as its criterion validity, arguably the single most import-
ant aspect of psychometric validation of a scale.48
Perhaps evenmore surprisingly, only two studies70,74 were iden-
tified that examined the psychometric properties of the GAD-7 in a
pregnant population, and only one74 was found to have satisfactory
methodological quality. As previously reported, the GAD-2 (i.e. the
initial two questions of the GAD-7) is the measure currently recom-
mended by NICE in the UK to screen for anxiety in pregnant
women, followed by administration of the GAD-7 if a woman
scores three or higher on the GAD-2.6 The only methodologically
robust study providing psychometric information on the GAD-7
in a pregnant population74 was also somewhat limited by focusing
exclusively on the screening accuracy of the GAD-7 for generalised
anxiety disorder, without providing any evidence of its screening
ability for other anxiety disorders in pregnancy. Furthermore, sub-
analyses to assess the screening ability of the GAD-2 as opposed to
the full GAD-7 were not conducted, thus leaving unanswered the
question of whether the GAD-2 can be used as an ultra-brief screen-
ing scale for problematic anxiety symptoms in pregnancy, as per
recent guidelines.6
Key best-evidence findings
Eight self-report measures were considered in the synthesis of the
best available evidence presented above. One further scale located
by this review (Pregnancy Anxiety Scale65) was not examined at
the best-evidence stage as the single study reporting its psychomet-
ric properties was rated poor for its methodological quality.65
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The key findings regarding anxiety items and domains identi-
fied as accurate indicators of antenatal anxiety, as discussed in the
Results, are summarised here. A complete list of all the identified
anxiety items and domains is also presented in the supplementary
Table 2. Furthermore, a table summarising all the correlations
between scales included in the review is available in supplementary
Table 3.
Items assessing excessive, generalised worry were found to be
psychometrically sound in the antenatal period in the EPDS,
HADS-A, BMWS, GAD-7 and STAI-S. Overall, there was strong
evidence of the psychometric robustness of items measuring the
domain of worry, with consistent findings in multiple studies of
good or excellent quality. Since excessive worry is essentially a cog-
nitive symptom, it could be argued that it is less susceptible to the
physical and physiological changes of pregnancy, and it remains
thus a good indicator of problematic anxiety in pregnancy as it is
in the general population.
A second anxiety domain that showed good evidence of its psy-
chometric soundness in pregnant populations concerned items
tapping into symptoms of fear or panic. Feelings of fear are
another important component of different anxiety disorders,
including panic disorder, agoraphobia, social anxiety disorder and
specific phobia.22,95 In this review, items assessing the fear/panic
domain were identified as psychometrically sound for use in preg-
nancy in various scales, including the HADS-A, the EPDS and
several pregnancy-specific anxiety scales.
Other specific symptoms identified by this review showed mod-
erate evidence of their screening ability in the assessment of ante-
natal anxiety. These included being excessively self-critical (EPDS,
item 3), feeling upset (STAI-S, item 6) and the experience of
nervous or motor tension (STAI-S, item 3). Although these symp-
toms may not appear to be specific to anxiety disorders, these find-
ings are in line with the well-established tripartite model of anxiety
and depression. This model postulates that depressive and anxiety
disorders share a common component of general emotional distress,
and the symptoms above can be categorised as manifestations of
general distress, which can be present in both depressive and
anxiety symptomatology.96
In relation to anxiety symptoms specifically related to preg-
nancy, fear of childbirth was shown to be a good indicator of preg-
nancy-specific anxiety. Specifically, pregnancy-specific anxiety
symptoms of fear related to giving birth exhibited strong evidence
of their psychometric value in the W-DEQ (several items) and the
PRAQ-R (two items related to fear of childbirth).
Items assessing persistent worries specifically related to preg-
nancy also showed good psychometric properties in the CWS, the
W-DEQ and the PRAQ-R. The worries with the strongest evidence
to support their screening accuracy related to concerns regarding
the health or safety of the baby and the possibility of miscarriage.
Other worries, including being in hospital and worrying about
future parenting showed only moderate evidence of their screening
value (see supplementary Table 2). It may be argued that most
women are likely to experience some degree of concern regarding
these aspects of pregnancy, but that in women experiencing clinical
levels of anxiety these worries may be more intense or persistent (i.e.
higher severity or frequency).
Strengths and limitations
The present review has a number of strengths. Only studies with
good or excellent methodological quality as determined by the
COSMIN checklist45 were included in the best-evidence synthesis,
thus guaranteeing that the conclusions reached were only based
on the strongest evidence available. We also used a comprehensive
search strategy that was devised to locate studies testing the
psychometric properties of both general anxiety scales and preg-
nancy-specific anxiety measures, unlike previous reviews that
were focused mostly or exclusively on general anxiety or preg-
nancy-specific anxiety scales.35,36 A second reviewer independently
checked a sample of studies, both in the initial phase of screening of
titles and abstract and for the quality assessment of included studies,
as per best practice recommendations for systematic reviews.37 The
review was reported according to the PRISMA reporting guide-
lines39 (see supplementary Table 4).
Several limitations also have to be acknowledged. Searches were
limited to research articles in English and restricted to publications
from 1991 onwards, this being the year when the first pregnancy-
specific anxiety scale was developed. The generalisability of the
review findings may also be somewhat limited by the fact that we
did not include studies from countries with substantial cultural dif-
ferences compared with the UK (i.e. Asian and African countries)
for which cultural equivalence of psychological symptoms cannot
be assumed.97,98
Implications and future directions
The accurate identification of women experiencing high levels of
anxiety symptoms in pregnancy is important and deserves clinical
attention for several reasons. Whereas postnatal depression has
been the focus of most research in perinatal mental health in the
past decades,21,24 there is now a substantial body of research indicat-
ing that anxiety in pregnant women is common and is associated
with increased risk for negative maternal and child outcomes.3,32,99
In the UK, the Royal College of General Practitioners has identified
perinatal mental health as a clinical priority100 and a recent report
from the London School of Economics has estimated the costs of
neglecting perinatal mental health problems in the UK to be a strik-
ing figure of £8.1 billion for every annual cohort of women, with
approximately three-quarters of this cost related to the adverse
long-term impact on children.101
Among the range of perinatalmental health problems that women
can experience, anxiety disorders have the highest prevalence.1
Consequently, a number of authors in recent years have advocated
the use of a brief scale for the universal screening of antenatal
anxiety.36,102 To the best of our knowledge, no anxiety scales have
been developed that are specific to the antenatal period and take
into account both general and pregnancy-specific anxiety symptoms.
Most studies have used measures of general anxiety, but the clinical
importance of including screening for pregnancy-specific anxiety
symptoms is supported by studies indicating that pregnancy-specific
anxiety may be a better predictor of adverse birth and child develop-
ment outcomes than general anxiety during pregnancy.34,103
Future research is needed to conduct robust psychometric studies
of existingmeasures in sufficiently large samples and ideally including
validation against a reference standard. The development of a new
anxiety scale specifically constructed for use in pregnancy and that
takes into account both general anxiety and symptoms of preg-
nancy-specific anxiety would also be highly desirable.
In sum, despite the research literature on prevalence, risk factors
and treatment of antenatal anxiety having decisively grown in recent
years,1,8,104 this review clearly points out how evidence regarding
the screening performance of anxiety scales for use in pregnancy,
including the one currently recommended by NICE, remains insuf-
ficient. The lack of measures with a sufficient evidence base consti-
tutes a considerable barrier to the identification of pregnant women
experiencing problematic anxiety symptoms, the initial step if they
are to be offered the appropriate support or treatment. This is, in
turn, an important missed opportunity for early prevention of nega-
tive health outcomes for women and their children. This review
improves the current understanding of anxiety symptomatology
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in pregnant women and may contribute to provide the theoretical
basis for the development of a psychometrically robust screening
scale for antenatal anxiety.
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